Category: Press Release - Page 155 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

Post published:February 11, 2021
Post category:Press Release

Read more about the article MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

Post published:February 11, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

Post published:February 11, 2021
Post category:Press Release

Read more about the article Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Post published:February 10, 2021
Post category:Press Release

Read more about the article Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Post published:February 10, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Post published:February 10, 2021
Post category:Press Release

Read more about the article Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275 Million in Gross Proceeds

Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275 Million in Gross Proceeds

Post published:February 10, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET

Post published:February 10, 2021
Post category:Press Release

Read more about the article Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study

Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study

Post published:February 10, 2021
Post category:Press Release

Read more about the article NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress

NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress

Post published:February 10, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.